Multiple System Atrophy clinical trials at UC Health

• North American Prodromal Synucleinopathy Consortium

  open to eligible people ages 18 years and up

  This study will enroll participants with idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.

  at UCLA

• More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

  Sorry, in progress, not accepting new patients

  This is a two-center (University of Colorado, University of California San Francisco) community-based comparative effectiveness study of outpatient palliative care for Parkinson's disease (PD) and related disorders (progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple systems atrophy (MSA), Lewy Body Dementia (LBD). In September 2018, the study was amended to also include Alzheimer's disease (AD) and related disorders (Frontotemporal Dementia (FTD), Primary Progressive Aphasia (PPA), Vascular Dementia). It will utilize a randomized stepped-wedge design to compare patient and caregiver outcomes between usual care in the community versus usual care augmented by palliative training and telemedicine support to provide other resources (e.g. social work).

  at UCSF

• Study of BHV-3241 in Subjects With Multiple System Atrophy

  Sorry, in progress, not accepting new patients

  The purpose of this study is to compare the efficacy of BHV-3241 versus placebo in subjects with Multiple System Atrophy

  at UCLA UCSD UCSF

Last updated: September 21, 2020